speb/financial-data huggingface dataset:
CVS.DE cash_flow (quarterly, 2025-03-31) — Change In Payable: 2983000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 2983000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Change In Receivables: -3053000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 1427000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -3053000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Changes In Cash: 1462000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Commercial Paper: 1259000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Common Stock: 49837000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -840000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 76929000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
CVS.DE income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 80192000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 22369000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Current Assets: 73191000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 1909000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Current Debt: 5670000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 7579000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 88961000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -169000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Deferred Tax: -169000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Defined Pension Benefit: 1924000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 1154000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 1154000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 1264000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.41
CVS.DE income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 1779000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — EBIT: 3402000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — EBITDA: 4556000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 1924000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — End Cash Position: 10346000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -2332000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 3813000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of Business: 236000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 59000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Goodwill: 91203000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 117773000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Gross PPE: 28560000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Gross Profit: 14396000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 1346000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Interest Expense: 785000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 785000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Inventory: 17385000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Invested Capital: 141639000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -762000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 24964000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 28906000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 14594000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 59040000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 73634000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -743000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Minority Interest: 181000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Minority Interests: -3000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -20000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Net Debt: 54634000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Net Income: 1779000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 1779000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 1782000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1779000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1779000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 1782000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 1782000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Net Interest Income: -785000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -18000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -1602000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -743000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -785000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -34000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 19000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Net PPE: 28560000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -743000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -859000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -40844000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 3664000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 3664000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 1924000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 4556000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Normalized Income: 1779000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 4556000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 236000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Operating Income: 3374000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Operating Revenue: 94588000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 1262000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 3527000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 4411000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 1570000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 59000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Other Income Expense: 28000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 26570000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Other Investments: 3942000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 5231000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 10292000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 28000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 11022000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Other Payable: 40909000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Other Properties: 28560000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Other Receivables: 22965000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 2578000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Payables: 57443000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 79812000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CVS.DE income_statement (quarterly, 2025-03-31) — Pretax Income: 2617000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 144000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -20000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -3552000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -743000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Receivables: 39625000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 80192000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1154000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -743000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 63768000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 3534000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Share Issued: 1779000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 126000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 76929000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -40844000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CVS.DE income_statement (quarterly, 2025-03-31) — Tax Provision: 835000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.32
CVS.DE balance_sheet (quarterly, 2025-03-31) — Total Assets: 255585000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 135969000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Total Debt: 81213000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 77110000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Total Expenses: 91214000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 178475000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 182394000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 89514000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 3374000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 517000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 36735000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Working Capital: -15770000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — +Operating Expense: 11212000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — +Total Revenue: 98915000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 17258000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 16350000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 24303000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Basic Average Shares: 1266000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Basic EPS: 0.81
CVS.DE cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 10346000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -607000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 16234000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Capital Stock: 50020000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 11787000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 14173000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -866000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 806000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -1024000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 1897000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 1212000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Change In Inventory: -51000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 132000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -118000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Change In Payable: 814000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 814000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Change In Receivables: -1086000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -309000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -1086000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Changes In Cash: 1679000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Commercial Paper: 3040000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Common Stock: 50020000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -866000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 77379000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Common Stock Payments: 0.00
CVS.DE income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 85322000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 23101000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Current Assets: 75649000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 1906000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Current Debt: 9200000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 11106000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 94162000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -114000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Deferred Tax: -114000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Defined Pension Benefit: 1858000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 1171000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 1171000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 1270000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.80
CVS.DE income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 1021000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — EBIT: 2410000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — EBITDA: 3581000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 1858000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — End Cash Position: 12025000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 806000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 1290000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of Business: 0.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 272000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Goodwill: 91203000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 117427000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Gross PPE: 28337000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Gross Profit: 13593000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Held To Maturity Securities: 1376000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Interest Expense: 763000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 763000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Inventory: 17447000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 143869000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -1024000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 25679000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 29858000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 14328000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 57290000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 71618000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -19000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Minority Interest: 172000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Minority Interests: 8000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -119000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Net Debt: 54703000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Net Income: 1021000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 1021000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 1013000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 1021000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 1021000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 1013000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 1013000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Net Interest Income: -763000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -302000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 1761000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -19000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -763000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -136000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 4000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Net PPE: 28337000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -607000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 1780000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -40048000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 3603000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 3603000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 1858000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 3581000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Normalized Income: 1021000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 1897000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 0.00
CVS.DE income_statement (quarterly, 2025-06-30) — Operating Income: 2381000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Operating Revenue: 98915000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 1267000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 3378000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 6160000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 1088000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 272000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Other Income Expense: 29000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 26224000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Other Investments: 4179000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 5214000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 9551000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 29000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 11212000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Other Payable: 41609000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Other Properties: 28337000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Other Receivables: 24301000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 2386000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Payables: 58867000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 81968000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CVS.DE income_statement (quarterly, 2025-06-30) — Pretax Income: 1647000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 47000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -119000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -3634000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -607000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Receivables: 40651000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 85322000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1171000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -19000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 63936000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 3332000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Share Issued: 1785000000.00
CVS.DE cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 136000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 77379000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -40048000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CVS.DE income_statement (quarterly, 2025-06-30) — Tax Provision: 634000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.39
CVS.DE balance_sheet (quarterly, 2025-06-30) — Total Assets: 258343000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 134669000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Total Debt: 82724000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 77551000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Total Expenses: 96534000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 180792000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 182694000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 86630000000.00
CVS.DE income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 2381000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 518000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 36849000000.00
CVS.DE balance_sheet (quarterly, 2025-06-30) — Working Capital: -18513000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — +Operating Expense: 11288000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — +Total Revenue: 102871000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 17764000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 16099000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 25857000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 12025000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -698000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 15916000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Capital Stock: 50181000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 9098000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 11232000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -846000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -1382000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -2087000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 796000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 1221000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Change In Inventory: -1653000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 381000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 1110000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Change In Payable: 1989000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 1989000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Change In Receivables: -3398000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -1571000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -3398000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Changes In Cash: -2673000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Commercial Paper: 1247000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Common Stock: 50181000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -846000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 72928000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
CVS.DE income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 89065000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 23415000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Current Assets: 77109000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1909000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Current Debt: 5328000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 7237000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 92695000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -157000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Deferred Tax: -157000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Defined Pension Benefit: 1934000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 1134000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 1134000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -3975000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — EBIT: -2698000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — EBITDA: -1564000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 1934000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — End Cash Position: 9352000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -1382000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 98000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of Business: -483000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Gain On Sale Of Business: 483000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 416000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Goodwill: 85478000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 111462000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Gross PPE: 28109000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Gross Profit: 13806000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Held To Maturity Securities: 1367000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 5725000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Interest Expense: 784000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 784000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Inventory: 18962000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Invested Capital: 138764000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -2087000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 27224000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 31553000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 3969000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 14007000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 60508000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 74515000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 3969000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -2847000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Minority Interest: 182000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Minority Interests: 15000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -290000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Net Debt: 56738000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Net Income: -3975000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -3975000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -3990000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -3975000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -3975000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -3990000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -3990000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Net Interest Income: -784000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -1085000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -671000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 1122000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -784000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 18000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -14000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Net PPE: 28109000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -698000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -1793000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -38534000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 3547000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 3547000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 1934000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 3678000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Normalized Income: 166180000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 796000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -483000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Operating Income: 2518000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Operating Revenue: 102871000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 1270000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 3058000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 4081000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1096000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 416000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Other Income Expense: -5216000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 25984000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Other Investments: 4329000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 5160000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 9526000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 26000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 11288000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Other Payable: 43183000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Other Properties: 28109000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Other Receivables: 27758000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 2134000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Payables: 60947000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 84362000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CVS.DE income_statement (quarterly, 2025-09-30) — Pretax Income: -3482000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 117000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -290000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -3859000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -698000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Receivables: 43857000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 89065000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1134000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -3719000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
CVS.DE income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 0.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 59107000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 2774000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Share Issued: 1786000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Special Income Charges: -5242000000.00
CVS.DE cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 138000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 72928000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -38534000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -1100820000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Tax Provision: 508000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CVS.DE balance_sheet (quarterly, 2025-09-30) — Total Assets: 255327000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 133436000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Total Debt: 81752000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 73110000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Total Expenses: 100353000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 182217000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 178218000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 89522000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -3207000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Total Unusual Items: -5242000000.00
CVS.DE income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -5242000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 516000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 36776000000.00
CVS.DE balance_sheet (quarterly, 2025-09-30) — Working Capital: -15586000000.00
CVS.DE income_statement (annual, 2025-12-31) — +Operating Expense: 44977000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — +Operating Expense: 11455000000.00
CVS.DE income_statement (annual, 2025-12-31) — +Total Revenue: 402067000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — +Total Revenue: 105693000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Accounts Payable: 17641000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 17641000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Accounts Receivable: 16316000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 16316000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -24744000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -24744000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 5725000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
CVS.DE balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 26721000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 26721000000.00
CVS.DE income_statement (annual, 2025-12-31) — Basic Average Shares: 1267000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Basic Average Shares: 1270000000.00
CVS.DE income_statement (annual, 2025-12-31) — Basic EPS: 1.40
CVS.DE income_statement (quarterly, 2025-12-31) — Basic EPS: 2.32
CVS.DE cash_flow (annual, 2025-12-31) — Beginning Cash Position: 8884000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 9352000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 4593000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 4593000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Capital Expenditure: -2832000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -784000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 15380000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 15380000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Capital Stock: 50402000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Capital Stock: 50402000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 8453000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 8453000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 10598000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 10598000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -3397000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -845000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -4940000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -2032000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -5871000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1998000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 10639000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 3390000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Change In Account Payable: 3855000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -1197000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Change In Inventory: -1267000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Change In Inventory: -285000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -2593000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -2005000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 2013000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -855000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Change In Payable: 3871000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Change In Payable: -1915000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 3871000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -1915000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Change In Receivables: -3498000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Change In Receivables: 4039000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Change In Working Capital: -1474000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -1021000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -3498000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 4039000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Changes In Cash: -172000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Changes In Cash: -640000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Commercial Paper: 0.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Commercial Paper: 0.00
CVS.DE balance_sheet (annual, 2025-12-31) — Common Stock: 50402000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Common Stock: 50402000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -3397000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -845000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Common Stock Equity: 75214000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 75214000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Common Stock Payments: 0.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
CVS.DE income_statement (annual, 2025-12-31) — Cost Of Revenue: 346705000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 92126000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 22387000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 22387000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Current Assets: 74714000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Current Assets: 74714000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1737000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1737000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Current Debt: 4068000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Current Debt: 4068000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 5805000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 5805000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Current Liabilities: 88692000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 88692000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Deferred Income Tax: 102000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 542000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Deferred Tax: 102000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Deferred Tax: 542000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Defined Pension Benefit: 1994000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Defined Pension Benefit: 1994000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 4606000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1147000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 4606000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 1147000000.00
CVS.DE income_statement (annual, 2025-12-31) — Diluted Average Shares: 1271000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 1277000000.00
CVS.DE income_statement (annual, 2025-12-31) — Diluted EPS: 1.39
CVS.DE income_statement (quarterly, 2025-12-31) — Diluted EPS: 2.30
CVS.DE income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 1768000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 2943000000.00
CVS.DE income_statement (annual, 2025-12-31) — EBIT: 5255000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — EBIT: 2141000000.00
CVS.DE income_statement (annual, 2025-12-31) — EBITDA: 9861000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — EBITDA: 3288000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Employee Benefits: 1994000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 1994000000.00
CVS.DE cash_flow (annual, 2025-12-31) — End Cash Position: 8712000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — End Cash Position: 8712000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Financing Cash Flow: -4940000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -2032000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Free Cash Flow: 7807000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 2606000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: -247000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of Business: 0.00
CVS.DE income_statement (annual, 2025-12-31) — Gain On Sale Of Business: 483000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Gain On Sale Of Business: 0.00
CVS.DE income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 0.00
CVS.DE balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 406000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 406000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Goodwill: 85478000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Goodwill: 85478000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 110986000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 110986000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Gross PPE: 52800000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Gross PPE: 52800000000.00
CVS.DE income_statement (annual, 2025-12-31) — Gross Profit: 55362000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Gross Profit: 13567000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Held To Maturity Securities: 1376000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Held To Maturity Securities: 1376000000.00
CVS.DE income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 5725000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 0.00
CVS.DE income_statement (annual, 2025-12-31) — Interest Expense: 3119000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Interest Expense: 787000000.00
CVS.DE income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 3119000000.00